CRISPR

CRISPR1-epoa

ID

ZDB-CRISPR-180626-1

Name

CRISPR1-epoa

Previous Names

None

Target

epoa (1)

Sequence

5' - CATCTGTGACCTGCGCGT - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

None

Genome Resources

None

Target Location

Constructs

No data available

Genomic Features

Genomic Feature	Affected Genomic Regions
zf3144	epoa

Expression

Gene expression in Wild Types + CRISPR1-epoa

No data available

Phenotype

Phenotype resulting from CRISPR1-epoa

Phenotype	Fish	Figures
nucleate erythrocyte decreased amount, abnormal	li1Tg + CRISPR1-epoa	Fig. 4 from She et al., 2017
pronephric duct decreased length, abnormal	li1Tg + CRISPR1-epoa	Fig. 2 from She et al., 2019
pronephric glomerulus increased size, abnormal	li1Tg + CRISPR1-epoa	Fig. 4 , Fig. S7 from She et al., 2017
pronephric glomerulus apoptotic process increased occurrence, abnormal	li1Tg + CRISPR1-epoa	Fig. 5 , Fig. S7 from She et al., 2017
pronephric tubule decreased length, abnormal	li1Tg + CRISPR1-epoa	Fig. 4 , Fig. S7 from She et al., 2017
pronephros decreased functionality, abnormal	li1Tg + CRISPR1-epoa	Fig. 4 from She et al., 2017
pronephros apoptotic process increased occurrence, abnormal	li1Tg + CRISPR1-epoa	Fig. 5 from She et al., 2017
renal glomerulus increased size, abnormal	li1Tg + CRISPR1-epoa	Fig. 2 from She et al., 2019
whole organism decreased concentration blood cell hemoglobin complex, abnormal	WT + CRISPR1-epoa	Fig. 2 from She et al., 2019

Phenotype of all Fish created by or utilizing CRISPR1-epoa

Phenotype	Fish	Conditions	Figures
whole organism epoa expression absent, abnormal	epoa^{zf3144/zf3144}	standard conditions	Fig. 1 from She et al., 2019
whole organism epob expression increased amount, abnormal	epoa^{zf3144/zf3144}	standard conditions	Fig. 3 from She et al., 2019
whole organism decreased concentration blood cell hemoglobin complex, abnormal	WT + CRISPR1-epoa	standard conditions	Fig. 2 from She et al., 2019
whole organism epoa expression decreased amount, abnormal	epoa^zf3144/+	standard conditions	Fig. 1 from She et al., 2019
pronephric duct decreased length, abnormal	li1Tg + CRISPR1-epoa	standard conditions	Fig. 2 from She et al., 2019
renal glomerulus increased size, abnormal	li1Tg + CRISPR1-epoa	standard conditions	Fig. 2 from She et al., 2019
pronephros apoptotic process increased occurrence, abnormal	li1Tg + CRISPR1-epoa	control	Fig. 5 from She et al., 2017
pronephric tubule decreased length, abnormal	li1Tg + CRISPR1-epoa	control	Fig. 4 , Fig. S7 from She et al., 2017
pronephric glomerulus increased size, abnormal	li1Tg + CRISPR1-epoa	control	Fig. 4 , Fig. S7 from She et al., 2017
pronephros decreased functionality, abnormal	li1Tg + CRISPR1-epoa	control	Fig. 4 from She et al., 2017
nucleate erythrocyte decreased amount, abnormal	li1Tg + CRISPR1-epoa	control	Fig. 4 from She et al., 2017
pronephric glomerulus apoptotic process increased occurrence, abnormal	li1Tg + CRISPR1-epoa	control	Fig. 5 , Fig. S7 from She et al., 2017
pronephric duct decreased length, abnormal	epoa^{zf3144/zf3144}; li1Tg + MO1-epob	standard conditions	Fig. 4 from She et al., 2019
renal glomerulus increased size, abnormal	epoa^{zf3144/zf3144}; li1Tg + MO1-epob	standard conditions	Fig. 4 from She et al., 2019

Citations